| 0 (0%) | 04-25 11:25 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 13.74 | 1-year : | 14.58 |
| Resists | First : | 11.76 | Second : | 12.48 |
| Pivot price | 11.3  |
|||
| Supports | First : | 10.59 | Second : | 8.81 |
| MAs | MA(5) : | 10.93  |
MA(20) : | 11.49 |
| MA(100) : | 12.91 |
MA(250) : | 14.72 |
|
| MACD | MACD : | -0.4 |
Signal : | -0.4 |
| %K %D | K(14,3) : | 23.4 |
D(3) : | 19.7 |
| RSI | RSI(14): 36.9 |
|||
| 52-week | High : | 20.71 | Low : | 10.59 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ CRSR ] has closed above bottom band by 35.7%. Bollinger Bands are 26.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 11.11 - 11.18 | 11.18 - 11.23 |
| Low: | 10.7 - 10.77 | 10.77 - 10.84 |
| Close: | 10.84 - 10.95 | 10.95 - 11.05 |
Wed, 24 Apr 2024
Congestion Revenue Rents Still Underfunded, CAISO DMM Says - RTO Insider
Sun, 21 Apr 2024
Corporate Resource (CRRS) Crumbles: Stock Goes Down 6.3% - Yahoo Movies Canada
Tue, 09 Apr 2024
AACR: Trio of studies highlights promising early results with new cancer therapies and targets - EurekAlert
Fri, 15 Sep 2023
A cancer-associated fibroblast subtypes-based signature enables the evaluation of immunotherapy response and ... - ScienceDirect.com
Fri, 05 May 2023
Probing excitations and cooperatively rearranging regions in deeply supercooled liquids - Nature.com
Tue, 07 Feb 2023
Statewatch | 3. Frontex and interoperable databases - Statewatch
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 103 (M) |
| Shares Float | 44 (M) |
| Held by Insiders | 3.1 (%) |
| Held by Institutions | 81.2 (%) |
| Shares Short | 1,560 (K) |
| Shares Short P.Month | 1,460 (K) |
| EPS | 0.02 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 6.46 |
| Profit Margin | -0.2 % |
| Operating Margin | 2.9 % |
| Return on Assets (ttm) | 0.4 % |
| Return on Equity (ttm) | -0.2 % |
| Qtrly Rev. Growth | 4.6 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 14.13 |
| EBITDA (p.s.) | 0.58 |
| Qtrly Earnings Growth | -53.3 % |
| Operating Cash Flow | 89 (M) |
| Levered Free Cash Flow | 71 (M) |
| PE Ratio | 367.83 |
| PEG Ratio | 0.1 |
| Price to Book value | 1.7 |
| Price to Sales | 0.78 |
| Price to Cash Flow | 12.78 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|